Project Management Associate II
Kite Pharma
Summary
4+ years of relevant experience and a BA or BS OR 3+ years of relevant experience and a MS or MBA
Job description
Specific Job Responsibilities
- Provides support to Project Managers to maintain and track various project activities including: timelines, budgets, action items, clinical trial materials requirements, resource plans and other project documents.
- May manage selected routine sub-projects.
- Participates in project and relevant departmental meetings and activities.
- Conducts routine internet searches and assembles information and documents as necessary.
- Posts and maintains routine information to online databases and shared folders as necessary.
- Identifies routine issues that may adversely affect a project and reports this information to the appropriate project manager.
- Assists project management associates in following-up on relevant routine departmental or project issues.
- Assists with routine project budgeting and resource planning.
- Follows up with sub-team members or working group regarding progress on routine action items updates and deadlines.
- Generates and maintains routine tracking and reporting tools as needed to provide input to the project teams, sub-teams or senior project management personnel.
- Generates routine reports utilizing various resources as required.
- Works with members of sub-teams and working groups to facilitate efficient workflow.
Basic Requirements
4+ years of relevant experience and a BA or BS OR 3+ years of relevant experience and a MS or MBA
Requirements
- 4+ years of relevant experience and a BA or BS OR 3+ years of relevant experience and a MS or MBA
- Relevant experience consists of work in a scientific field or equivalent experience in association with R&D project teams and/or in cross-functional project management activities
Benefits
- Medical, Dental & Vision
- Life Insurance
- Paid Time Off
- Discretionary Annual Bonus
- Discretionary Stock-Based LTI
Company overview
Kite Pharma, Inc. is an American biotechnology company specializing in cancer immunotherapy with a primary focus on genetically engineered autologous CAR T cell therapy. Founded in 2009 and headquartered in Santa Monica, California, Kite was acquired by Gilead Sciences in 2017 for $11.9 billion. The company develops cell-based therapies that reengineer a patient's own immune cells to attack and fight cancer cells, representing a personalized approach to cancer treatment. Kite's lead product, Yescarta (axicabtagene ciloleucel), was the first CAR T therapy approved by the FDA for treating adult patients with relapsed or refractory large B-cell lymphoma. With approximately 2,000 employees and manufacturing facilities in California, Maryland, and the Netherlands, Kite operates as an independent company within Gilead Sciences while maintaining its singular focus on advancing cell therapy to treat and potentially cure cancer. The company's innovative approach represents a paradigm shift in cancer treatment, moving away from traditional pharmaceutical manufacturing to individualized cell therapies created one patient at a time.